Cargando…

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study

Detalles Bibliográficos
Autores principales:	Compalati, Enrico, Ortolani, Claudio, Pastorello, Elide, Moscato, Gianna, Berra, Daniele, Tosi, Anna, Mauro, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082075/ http://dx.doi.org/10.1186/1939-4551-7-S1-P1

Ejemplares similares

The relative clinical impact of sublingual immunotherapy with carbamylated monomeric allergoids on allergic respiratory symptoms
por: Compalati, Enrico, et al.
Publicado: (2015)

Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite
por: Compalati, Enrico, et al.
Publicado: (2015)

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients
por: Hüser, C., et al.
Publicado: (2016)

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
por: Blaiss, Michael, et al.
Publicado: (2014)

Ragweed pollen concentration predicts seasonal rhino-conjunctivitis and asthma severity in patients allergic to ragweed
por: Bonini, Maira, et al.
Publicado: (2022)

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use
por: Gawchik, Sandra, et al.
Publicado: (2014)

Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study
por: Di Gioacchino, Mario, et al.
Publicado: (2022)

Ragweed allergy: Pollen count and sensitization and allergy prevalence in two Italian allergy centers
por: Ariano, Renato, et al.
Publicado: (2015)

Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects
por: Bernstein, David I, et al.
Publicado: (2014)

Peripheral effector memory regulatory T cells are incremented and functionally enhanced in successful mite monomeric allergoid sublingual immunotherapy
por: Petrarca, Claudia, et al.
Publicado: (2020)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2021)

AN HETEROPHILE FACTOR IN RAGWEED POLLEN
por: Sammis, F. Eastty
Publicado: (1940)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

29 Allergic Rhinitis to Ragweed Pollen
por: Bocsan, Ioana Corina, et al.
Publicado: (2012)

11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
por: Compalati, Enrico, et al.
Publicado: (2012)

Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
por: Bożek, Andrzej, et al.
Publicado: (2017)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022)

Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid
por: Gawlik, Radoslaw, et al.
Publicado: (2016)

Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
por: Ortolani, Claudio, et al.
Publicado: (2020)

The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis
por: Maloney, Jennifer, et al.
Publicado: (2014)

Antigenic relationship between mugwort and ragweed pollens by crossed immunoelectrophoresis.
por: Park, H. S., et al.
Publicado: (1994)

Your Grandchildren’s Pollen? Modeling the Future of Ragweed Sensitization in Europe
por: Schmidt, Charles W.
Publicado: (2017)

Symptom patterns and comparison of diagnostic methods in ragweed pollen allergy
por: Haidar, Laura, et al.
Publicado: (2021)

A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy
por: Bilancia, Massimo, et al.
Publicado: (2020)

ALLERGENIC RELATIONSHIP OF THE POLLENS OF DWARF AND GIANT RAGWEED TO SEVERAL OF THEIR BOTANIC RELATIVES
por: Simon, Frank A.
Publicado: (1943)

In children allergic to ragweed pollen, nasal inflammation is not influenced by monosensitization or polysensitization
por: Gelardi, Matteo, et al.
Publicado: (2016)

Biologic Pollution Due to Ambrosia (Ragweed) Pollen in Urban Environment of Bucharest
por: Leru, Polliana Mihaela, et al.
Publicado: (2022)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice
por: Soria, I., et al.
Publicado: (2018)

Is ragweed pollen allergenicity governed by environmental conditions during plant growth and flowering?
por: Ghiani, Alessandra, et al.
Publicado: (2016)

Mesoscale atmospheric transport of ragweed pollen allergens from infected to uninfected areas
por: Grewling, Ł., et al.
Publicado: (2016)

Characterization of Patients with Allergic Rhinitis to Ragweed Pollen in Two Distinct Regions of Romania
por: Bocsan, Ioana Corina, et al.
Publicado: (2019)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
por: Horak, F, et al.
Publicado: (2009)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
por: Malling, H-J, et al.
Publicado: (2009)

A major step forward for sublingual immunotherapy: the quality of 5-grass pollen tablet is recognized also in Italy
por: Ciprandi, Giorgio
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0cbu58oakc43fqqhjgsco68fpc